SARS-CoV-2 and D-dimer

16 July 2020

Current information on increased D-dimer, cardiac Troponin (cTn), and BNP biomarkers in patients with laboratory-confirmed SARS-CoV-2 infections

 

In response to the number and diversity of studies that have emerged surrounding SARS-CoV-2 infections and the suspected link to thrombotic and cardiac events, Quidel felt it prudent to summarise and provide a technical bulletin of the recent literature on these topics. Please note that there is no direct link to their products and their intended use, as stated in the Package Inserts.

There are limitations of the data aggregated in this technical bulletin due to the changing environment surrounding SARS-CoV-2 and the lack of controlled studies. We recommend that customers continue to keep up to date with the latest literature and relevant society recommendations. These guidelines and recommendations change rapidly, so please reference them online for real time updates: ESC, ACC, IFCC, WHO, CDC, NIH, AMA, AHA.

Please find the full technical bulletin below for your reference or download a PDF version of the document here.

NG Biotech CARBA 5
Because there's more to public health than COVID-19...

"We love the ease and accuracy of the NG CARBA-5 lateral flow test. It has decreased our turnaround times and means we no longer need the reference laboratory to confirm our presumptive CPO results." - Holly Ciesielczuk, Senior Clinical Scientist at Barts Health NHS Trust

Read More